Endothelins in chronic diabetic complications

Author： Khan Zia Ali   Chakrabarti Subrata  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.81, Iss.6, 2003-06, pp. : 622-634

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Chronic Treatment with Lisinopril on Cardiovascular Complications in Streptozotocin Diabetic and Doca Hypertensive Rats

By Sevak A.R.   Goyal R.K.  

Pharmacological Research, Vol. 34, Iss. 5, 1996-11 ,pp. : 201-209

Academic Press

Access to resources Recommend Favorite

Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications

By Chiu Jane   Xu Bing Y.   Chen Shali   Feng Biao   Chakrabarti Subrata  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 6, 2008-06 ,pp. : 365-372

NRC Research Press

Access to resources Recommend Favorite

Atorvastatin and Diabetic Vascular Complications

By  

Current Pharmaceutical Design, Vol. 12, Iss. 12, 2006-04 ,pp. : 1549-1554

Bentham Science Publishers

Access to resources Recommend Favorite

ACE2 and Diabetic Complications

By  

Current Pharmaceutical Design, Vol. 13, Iss. 26, 2007-09 ,pp. : 2730-2735

Bentham Science Publishers

Access to resources Recommend Favorite

The Pharmacology of Diabetic Complications

By  

Current Medicinal Chemistry, Vol. 10, Iss. 15, 2003-08 ,pp. : 1317-1327

Bentham Science Publishers

Access to resources Recommend Favorite